IRulya Therapeutics Inc. IRLA
40.59 USD +2.14 (+5.57%)
Regular-session close
39.50 -1.09 -2.69%
Pre-market · Nov 19, 4:31 AM ET
38.49 Day range 42.73
15.10 52-week range 910.00
- YTD
- -93.94%
- 1 year
- -89.37%
News
benzinga.com Citizens Maintains Market Outperform on IRulya Therapeutics, Raises Price Target to $86 Citizens analyst Jonathan Wolleben maintains IRulya Therapeutics (NASDAQ:IRLA) with a Market Outperform and raises the price target from $77 to $86.
benzinga.com IRulya Therapeutics Q3 EPS $(2.31) Beats $(19.83) Estimate IRulya Therapeutics (NASDAQ:IRLA) reported quarterly losses of $(2.31) per share which beat the analyst consensus estimate of $(19.83) by 88.35 percent. This is a 95.36 percent increase over losses…
globenewswire.com IRulya Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results Name changed from Quince Therapeutics, Inc. to IRulya Therapeutics Inc.; common stock began trading on the Nasdaq Capital Market under the ticker “IRLA” on October 12, 2026 Phase 2 data in…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Pharvaris (NASDAQ:PHVS) stock moved upwards by 19.4% to $36.9 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.0 billion. CalciMedica (NASDAQ:CALC)…
